Amended Current Report Filing (8-k/a)
May 20 2020 - 6:04AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
AMENDMENT
NO. 1
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of report (Date of earliest event reported): May 8, 2020
Commission
File Number: 000-53497
Vivos
Inc.
(Exact
name of registrant as specified in its charter.)
Delaware
|
|
80-0138937
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(IRS
Employer
Identification
No.)
|
719
Jadwin Avenue, Richland, Washington 99352
(Address
of principal executive offices)
509-736-4000
(Registrant’s
Telephone number)
Not
Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2)
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of exchange on which registered
|
None
|
|
RDGL
|
|
N/A
|
EXPLANATORY
NOTE
This
Amendment No. 1 on Form 8-K/A (the “Amended Current Report”) to the Current Report on Form 8-K filed with the
Securities and Exchange Commission (the “SEC”) on May 8, 2020 (the “Original Filing”) by
Vivos Inc. (the “Company”) is being filed to supplement the disclosure previously reported under Item 8.01
of the Original Filing, including providing additional information with respect to the events that occurred which resulted in
the Company’s reliance on the Order (as defined below).
Except
as stated herein, this Amended Current Report does not reflect events occurring after the filing of the Original Filing and no
attempt has been made in this Amended Current Report to modify or update other disclosures as presented in the Original Filing.
Accordingly, this Amended Current Report should be read in conjunction with the Original Filing and our filings with the SEC subsequent
to the filing of the Original Filing.
Item
8.01 Other Events.
As
reported in the Original Filing, on March 4, 2020, the U.S. Securities and Exchange Commission (the “Commission”)
issued an order under Section 36 (Release No. 34-88318), of the Securities Exchange Act of 1934, as amended (“Exchange
Act”), as modified on March 25, 2020 (Release No. 34-88465), granting exemptions from specified provisions of the Exchange
Act and certain rules thereunder (the “Order”). The Order provides that a registrant subject to the reporting
requirements of Exchange Act Section 13(a) or 15(d), and any person required to make any filings with respect to such a registrant,
is exempt from any requirement to file or furnish materials with the Commission under Exchange Act Sections 13(a), 13(f), 13(g),
14(a), 14(c), 14(f), 15(d) and Regulations 13A, Regulation 13D-G (except for those provisions mandating the filing of Schedule
13D or amendments to Schedule 13D), 14A, 14C and 15D, and Exchange Act Rules 13f-1, and 14f-1, as applicable, where certain conditions
are satisfied.
In
connection with the filing of the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2020, the
Company is relying on the Order as a result of the circumstances set forth below.
The
State of Washington, where the Company has its base operations as well as certain vendors located within Seattle was one of the
epicenters for the coronavirus pandemic (“COVID-19”). The Company has closed its offices and requested that
all employees work remotely until further notice. Employees affected include certain of its key personnel responsible for assisting
the Company in the preparation of its financial statements. In view of these ongoing circumstances, the Company has been unable
to timely provide its auditors and accountants with financial records to provide consent, and therefore allow the Company to file
a timely and accurate Quarterly Report on Form 10-Q for the period ending March 31, 2020 by the prescribed date without undue
hardship and expense to the Company.
Accordingly,
in reliance upon the Order, the Company expects to file its Quarterly Report on Form 10-Q for the period ending March 31, 2020,
no later than June 29, 2020 (which is 45 days from the original filing deadline of May 15, 2020).
As
previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Commission on
April 28, 2020, the Company is supplementing the risk factors previously disclosed in the Company’s Annual Report on Form
10-K for the year ended December 31, 2018 and its subsequent Quarterly Reports on Form 10-Q with the following risk factor:
Pandemics
including COVID-19 may adversely affect our business.
The
recent unprecedented events related to COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2), have had significant
health, economic, and market impacts and may have short-term and long-term adverse effects on our business that we cannot predict
as the global pandemic continues to evolve. The extent and effectiveness of responses by governments and other organizations also
cannot be predicted.
Our
ability to access the capital markets is unknown during the COVID-19 pandemic. Any such limitation on available financing would
adversely affect our business.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date:
May 19, 2020
|
Vivos
Inc.
|
|
|
|
|
By:
|
/s/
Michael Korenko
|
|
Name:
|
Michael
Korenko
|
|
Title:
|
Chief
Executive Officer
|
Vivos (QB) (USOTC:RDGL)
Historical Stock Chart
From Oct 2024 to Nov 2024
Vivos (QB) (USOTC:RDGL)
Historical Stock Chart
From Nov 2023 to Nov 2024